NitinOhriMD
Radiation Oncology • New York, NYAssistant Professor, Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine
Dr. Ohri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E 126th St
New York, NY 10035Phone+1 646-968-9064
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2008 - 2012
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2007 - 2008- Washington University in St. Louis School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2012 - 2025
PA State Medical License 2008 - 2012- American Board of Radiology Radiation Oncology
Clinical Trials
- Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
- PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer Start of enrollment: 2013 Jul 01
- Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer Start of enrollment: 2015 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).Nitin Ohri, William R Bodner, Rafi Kabarriti, Viswanathan Shankar, Rasim Gucalp
International Journal of Radiation Oncology, Biology, Physics. 2025-01-23 - Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?J Humberto Rodriguez-Quintero, Rajika Jindani, Roger Zhu, Isaac Loh, Mohamed K Kamel
JTO Clinical and Research Reports. 2025-01-01 - Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial.Laura A Dawson, Kathryn A Winter, Jennifer J Knox, Andrew X Zhu, Sunil Krishnan
JAMA Oncology. 2024-12-19
Journal Articles
- Radiation Therapy for Patients with Newly Diagnosed Metastatic Head and Neck Squamous Cell CarcinomaRafi Kabarriti, Nitin Ohri, Chandan Guha, Madhur K Garg, Sujith Baliga, Shalom Kalnicki, Head & Neck
Press Mentions
AI Model Predicts the Likelihood of Unplanned Hospitalization During Radiation Treatments for CancerOctober 24th, 2022
Patient Step Counts Predict Lung Cancer Treatment Outcomes, Study FindsJanuary 8th, 2020
Koneksa Health Announces Poster Presentation at ASCO Quality Care SymposiumSeptember 6th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
